Piermont Capital Management’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-304
| Closed | -$223K | – | 179 |
|
|
2018
Q2 | $223K | Buy |
+304
| New | +$223K | 0.07% | 225 |
|
|
2017
Q4 | – | Sell |
-1,539
| Closed | -$554K | – | 254 |
|
|
2017
Q3 | $554K | Sell |
1,539
-1,513
| -50% | -$545K | 0.18% | 145 |
|
|
2017
Q2 | $895K | Buy |
+3,052
| New | +$895K | 0.26% | 160 |
|
|
2016
Q4 | – | Sell |
-2,072
| Closed | -$534K | – | 265 |
|
|
2016
Q3 | $534K | Sell |
2,072
-1,933
| -48% | -$498K | 0.13% | 231 |
|
|
2016
Q2 | $855K | Buy |
4,005
+1,944
| +94% | +$415K | 0.22% | 182 |
|
|
2016
Q1 | $425K | Buy |
+2,061
| New | +$425K | 0.14% | 175 |
|